Work Here?
Overview
9amHealth provides virtual cardiometabolic care to prevent and manage chronic conditions like diabetes, obesity, high cholesterol, and hypertension. The service uses a B2B2C model with employers, health plans, and PBMs, and also offers a direct-to-consumer subscription. Its platform delivers personalized treatment plans, access to endocrinologists and pharmacists, at-home lab testing, connected devices, and prescription delivery, guided by step-therapy from lifestyle changes and generics to GLP-1s when needed. Partnerships with Novo Nordisk, Eli Lilly, and pharmacy networks help expand affordable access to medications, while the goal is to improve outcomes by making cardiometabolic care more accessible and effective.
About 9amHealth
Industries
Data & Analytics
Consumer Software
Enterprise Software
Healthcare
Company Size
51-200
Company Stage
Series B
Total Funding
$55.2M
Headquarters
San Diego, California
Founded
2021
Get referred to 9amHealth
See people who can refer or advise you
Simplify's Take
What believers are saying
- May 13, 2026 Series B added $26M from Define Ventures and others.
- March 4, 2026 Withings partnership adds connected scales and blood-pressure monitoring.
- November 21, 2025 Novo Nordisk and Lilly partnership widened employer GLP-1 access.
What critics are saying
- 9amHealth's 2026 employer push depends on GLP-1 pricing wars with Lilly and Novo.
- Expansion beyond cardiometabolic care after May 2026 funding risks dilution before product-market fit.
- If Fortune 100 savings do not recur, employer contracts and 9amHealth's model collapse.
What makes 9amHealth unique
- Co-founders Frank Westermann and Anton Kittelberger previously built mySugr, sold to Roche in 2017.
- 9amHealth combines specialists, at-home labs, devices, and medication delivery in one workflow.
- By May 2026, 9amHealth had $55.6M funding and Fortune 100 savings evidence.
Help us improve and share your feedback! Did you find this helpful?
Funding
Total Funding
$55.2M
Below
Industry Average
Funded Over
4 Rounds
Founders FundIndustry standards
Benefits
Health Insurance
Vision Insurance
Dental Insurance
Paid Vacation
Flexible Work Hours
Growth & Insights and Company News
6 month growth
↓ -1%1 year growth
↓ -6%2 year growth
↓ -5%9amHealth, a virtual specialty care platform, has raised $26 million in Series B funding led by Define Ventures, with participation from SemperVirens VC, Catalio Capital Management and NewHealth Ventures. The company says it has generated over $50 million in projected medical and pharmacy savings across two Fortune 100 employers. Founded in 2021, 9amHealth currently focuses on cardiometabolic conditions including obesity, diabetes, hypertension and hyperlipidemia. The platform combines clinical protocols, laboratory testing, medication management and continuous care delivery. The funding will support expansion into additional high-cost chronic conditions, which the company says account for up to 70% of employer pharmacy spend. 9amHealth uses AI-enabled clinical workflows to manage complex conditions at scale, partnering with employers, health plans and pharmacy benefit managers.
9amHealth, a San Diego, CA-based virtual provider of cardiometabolic health care, raised $9.5M in Series A extension funding.
Calm/Storm Ventures has strong roots with business angel Hansi Hansmann, Speedinvest, and Runtastic. After the first focus on HealthTech, the next fund is about financing the best founders in Austria. 2021 was a hype year that doubled the number of unicorns worldwide to 1,058 from 586 in 2020 after massive amounts of venture capital were pumped into these tech companies. Everything was different in 2022, when mass layoffs, downrounds, and a lack of venture capital dominated the headlines. The founders and partners of the Austrian VC Calm/Storm Ventures know these two poles very well. Taken together, Lucanus Polagnoli (ex-Speedinvest), Hansi Hansmann, and Alfred Luger (ex-Runtastic) weigh in on more than 180 investments as fund managers and business angels
Nach jahrelanger Erfahrung als „einfacher“ Investor startete PUSH Ventures im vergangenen Jahr einen ersten großen und registrierten Investment-Fonds. Lukas Püspök und Laurenz Simbruner, die beiden Partner hinter dem VC, konnten den Fonds mit etwas mehr als 20 Millionen Euro auffüllen. Investiert werden soll in Health- sowie Climate-Startups — mit jeder Menge (familiären) Rückenwind. Der Fokus auf Klima-Startups verwundert nicht, blickt doch gerade Familie Püspök auf jahrelange Projekte in diesem Sektor zurück: Seit 1997 beschäftigt sich das Familienunternehmen mit der Stromerzeugung aus erneuerbarer Energie. Vor mehr als 20 Jahren begann die Geschichte mit der Entwicklung und Errichtung eines der ersten Windparks im Burgenland. Über zwei Jahrzehnte später setzt die nächste Generation die nächsten Schritte, gemeinsam mit Laurenz Simbruner und Investment-Manager David Aigner
Calm/Storm Ventures hat mit Business Angel Hansi Hansmann, Speedinvest und Runtastic kräftige Wurzeln. Nach dem ersten Fokus auf HealthTech geht es beim nächsten Fonds darum, die besten Gründer:innen Österreichs zu finanzieren. 2021 war ein Hype-Jahr, das die Zahl der Unicorns weltweit von 586 im Jahr 2020 auf 1.058 verdoppelte, nachdem enorme Mengen an Risikokapital in diese Tech-Firmen gepumpt wurden. 2022 war alles anders, da dominierten Massenkündigungen, Downrounds und fehlendes Risikokapital die Schlagzeilen. Diese beiden Pole kennen die Gründer und Partner des österreichischen VCs Calm/Storm Ventures genau. Zusammengerechnet bringen Lucanus Polagnoli (Ex-Speedinvest), Hansi Hansmann und Alfred Luger (Ex-Runtastic) mehr als 180 Investments als Fonds-Manager bzw
9amHealth is Hiring for 17 Jobs on Simplify!
Find jobs on Simplify and start your career today
About 9amHealth
Industries
Data & Analytics
Consumer Software
Enterprise Software
Healthcare
Company Size
51-200
Company Stage
Series B
Total Funding
$55.2M
Headquarters
San Diego, California
Founded
2021
9amHealth is Hiring for 17 Jobs on Simplify!
Find jobs on Simplify and start your career today